ArticleJournal of gastroenterology2015

Predictive value of serum HER2 ECD in patients with HER2-positive advanced gastric cancer treated with trastuzumab plus chemotherapy.

Jun Zhou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.